nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethizole—ALB—Estropipate—osteoporosis	0.404	0.407	CbGbCtD
Sulfamethizole—CYP2C9—Estropipate—osteoporosis	0.218	0.219	CbGbCtD
Sulfamethizole—ALB—Estradiol—osteoporosis	0.168	0.169	CbGbCtD
Sulfamethizole—CYP2C9—Cholecalciferol—osteoporosis	0.112	0.113	CbGbCtD
Sulfamethizole—CYP2C9—Estradiol—osteoporosis	0.0904	0.0911	CbGbCtD
Sulfamethizole—Sulfathiazole—CYP19A1—osteoporosis	0.00341	0.646	CrCbGaD
Sulfamethizole—Sulfanilamide—CA2—osteoporosis	0.00186	0.353	CrCbGaD
Sulfamethizole—ALB—Platelet degranulation—WDR1—osteoporosis	0.000104	0.0354	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	9.88e-05	0.0337	CbGpPWpGaD
Sulfamethizole—ALB—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	9.87e-05	0.0337	CbGpPWpGaD
Sulfamethizole—ALB—Lipoprotein metabolism—P4HB—osteoporosis	9.71e-05	0.0331	CbGpPWpGaD
Sulfamethizole—ALB—Lipid and lipoprotein metabolism—MGLL—osteoporosis	9.49e-05	0.0324	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—CAP1—osteoporosis	8.2e-05	0.028	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—PRDX3—osteoporosis	7.97e-05	0.0272	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	7.81e-05	0.0267	CbGpPWpGaD
Sulfamethizole—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—osteoporosis	7.42e-05	0.0253	CbGpPWpGaD
Sulfamethizole—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	6.45e-05	0.022	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—PLEK—osteoporosis	5.96e-05	0.0203	CbGpPWpGaD
Sulfamethizole—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	5.7e-05	0.0195	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	5.68e-05	0.0194	CbGpPWpGaD
Sulfamethizole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	5.37e-05	0.0183	CbGpPWpGaD
Sulfamethizole—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	5.3e-05	0.0181	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—TLN1—osteoporosis	5.14e-05	0.0175	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—VCL—osteoporosis	5.07e-05	0.0173	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	4.89e-05	0.0167	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	4.83e-05	0.0165	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	4.6e-05	0.0157	CbGpPWpGaD
Sulfamethizole—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	4.35e-05	0.0148	CbGpPWpGaD
Sulfamethizole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	3.88e-05	0.0132	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—FGA—osteoporosis	3.84e-05	0.0131	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	3.66e-05	0.0125	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	3.64e-05	0.0124	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—FGB—osteoporosis	3.49e-05	0.0119	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	3.35e-05	0.0114	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	3.33e-05	0.0114	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	2.95e-05	0.0101	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	2.89e-05	0.00986	CbGpPWpGaD
Sulfamethizole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.82e-05	0.00962	CbGpPWpGaD
Sulfamethizole—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.78e-05	0.00949	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—SOD2—osteoporosis	2.72e-05	0.00929	CbGpPWpGaD
Sulfamethizole—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	2.66e-05	0.00906	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	2.64e-05	0.00902	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—GPX1—osteoporosis	2.6e-05	0.00886	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—MTHFR—osteoporosis	2.4e-05	0.00818	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—WDR1—osteoporosis	2.37e-05	0.00809	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	2.31e-05	0.00788	CbGpPWpGaD
Sulfamethizole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.29e-05	0.0078	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	2.28e-05	0.00777	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	2.28e-05	0.00777	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	2.25e-05	0.00767	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	2.16e-05	0.00738	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	2.06e-05	0.00704	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	1.91e-05	0.0065	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.89e-05	0.00644	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	1.88e-05	0.00641	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—CAP1—osteoporosis	1.88e-05	0.0064	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.79e-05	0.0061	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	1.75e-05	0.00597	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	1.7e-05	0.00581	CbGpPWpGaD
Sulfamethizole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.69e-05	0.00578	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—IGF1—osteoporosis	1.58e-05	0.0054	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	1.55e-05	0.00529	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.55e-05	0.00527	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	1.51e-05	0.00514	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—MGLL—osteoporosis	1.49e-05	0.00508	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.46e-05	0.005	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—IL1B—osteoporosis	1.42e-05	0.00485	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.39e-05	0.00475	CbGpPWpGaD
Sulfamethizole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.37e-05	0.00469	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PLEK—osteoporosis	1.36e-05	0.00465	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—ANXA2—osteoporosis	1.36e-05	0.00465	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.36e-05	0.00463	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	1.27e-05	0.00433	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	1.21e-05	0.00414	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	1.2e-05	0.00408	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.18e-05	0.00402	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—TLN1—osteoporosis	1.17e-05	0.00401	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—VCL—osteoporosis	1.16e-05	0.00395	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.14e-05	0.00389	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	1.13e-05	0.00386	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.11e-05	0.00379	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.08e-05	0.0037	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—TNF—osteoporosis	1.03e-05	0.00352	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	1.02e-05	0.00349	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—RAP1A—osteoporosis	9.68e-06	0.0033	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—TGFB1—osteoporosis	9.48e-06	0.00323	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.22e-06	0.00314	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	9.03e-06	0.00308	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.87e-06	0.00303	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—FGA—osteoporosis	8.78e-06	0.00299	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PKM—osteoporosis	8.41e-06	0.00287	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—FDPS—osteoporosis	8.41e-06	0.00287	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—IL6—osteoporosis	8.33e-06	0.00284	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—TNF—osteoporosis	8.2e-06	0.0028	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—FGB—osteoporosis	7.99e-06	0.00272	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GPD2—osteoporosis	7.97e-06	0.00272	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PGLS—osteoporosis	7.97e-06	0.00272	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.55e-06	0.00257	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—POMC—osteoporosis	7.3e-06	0.00249	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ATIC—osteoporosis	7.29e-06	0.00249	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PNP—osteoporosis	7.29e-06	0.00249	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	7.02e-06	0.00239	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PKM—osteoporosis	6.88e-06	0.00235	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—FDPS—osteoporosis	6.88e-06	0.00235	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—IL6—osteoporosis	6.62e-06	0.00226	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GPD2—osteoporosis	6.52e-06	0.00223	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PGLS—osteoporosis	6.52e-06	0.00223	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—OXCT1—osteoporosis	6.2e-06	0.00211	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CA2—osteoporosis	6.2e-06	0.00211	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—MGLL—osteoporosis	6.04e-06	0.00206	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PNP—osteoporosis	5.97e-06	0.00204	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ATIC—osteoporosis	5.97e-06	0.00204	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.7e-06	0.00194	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—IDH2—osteoporosis	5.14e-06	0.00175	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—OXCT1—osteoporosis	5.07e-06	0.00173	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CA2—osteoporosis	5.07e-06	0.00173	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—MGLL—osteoporosis	4.94e-06	0.00169	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CYP27A1—osteoporosis	4.83e-06	0.00165	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ACP5—osteoporosis	4.7e-06	0.0016	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.66e-06	0.00159	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.64e-06	0.00158	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.42e-06	0.00151	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—TPI1—osteoporosis	4.37e-06	0.00149	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	4.21e-06	0.00143	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—IDH2—osteoporosis	4.2e-06	0.00143	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—P4HB—osteoporosis	4.11e-06	0.0014	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GAPDH—osteoporosis	4.03e-06	0.00137	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CYP27A1—osteoporosis	3.95e-06	0.00135	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—RAP1A—osteoporosis	3.92e-06	0.00134	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ACP5—osteoporosis	3.84e-06	0.00131	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.8e-06	0.00129	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—IGF1—osteoporosis	3.62e-06	0.00123	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—TPI1—osteoporosis	3.57e-06	0.00122	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.42e-06	0.00117	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—P4HB—osteoporosis	3.36e-06	0.00115	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GAPDH—osteoporosis	3.3e-06	0.00113	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—RAP1A—osteoporosis	3.21e-06	0.0011	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ENO1—osteoporosis	3.17e-06	0.00108	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PSMA5—osteoporosis	3.13e-06	0.00107	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PSMA2—osteoporosis	3.13e-06	0.00107	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.8e-06	0.000956	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ENO1—osteoporosis	2.6e-06	0.000886	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PSMA2—osteoporosis	2.56e-06	0.000873	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PSMA5—osteoporosis	2.56e-06	0.000873	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CYP19A1—osteoporosis	2.54e-06	0.000865	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—TGFB1—osteoporosis	2.17e-06	0.00074	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CYP19A1—osteoporosis	2.08e-06	0.000708	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ADCY5—osteoporosis	2.07e-06	0.000707	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GPX1—osteoporosis	2.07e-06	0.000704	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—MTHFR—osteoporosis	1.91e-06	0.00065	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ADCY5—osteoporosis	1.7e-06	0.000579	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GPX1—osteoporosis	1.69e-06	0.000577	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—MTHFR—osteoporosis	1.56e-06	0.000532	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—POMC—osteoporosis	1.52e-06	0.00052	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—POMC—osteoporosis	1.25e-06	0.000426	CbGpPWpGaD
